PortfoliosLab logoPortfoliosLab logo
PMVP vs. PRLD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PMVP vs. PRLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PMV Pharmaceuticals, Inc. (PMVP) and Prelude Therapeutics Incorporated (PRLD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PMVP achieves a -10.40% return, which is significantly lower than PRLD's 51.38% return.


PMVP

1D
0.90%
1M
-8.20%
6M
5.66%
YTD
-10.40%
1Y
-20.00%
3Y*
-44.64%
5Y*
-50.16%
10Y*
ALL TIME*
-44.46%

PRLD

1D
-4.57%
1M
-10.59%
6M
116.26%
YTD
51.38%
1Y
430.00%
3Y*
6.15%
5Y*
-32.60%
10Y*
ALL TIME*
-25.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$494.13K$487.49K$457.02K
$1.90M$1.67M$1.93M

PMVP vs. PRLD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
PMVP
PMV Pharmaceuticals, Inc.
-10.40%-17.22%-51.29%-64.37%-62.34%-62.45%75.74%
PRLD
Prelude Therapeutics Incorporated
51.38%127.45%-70.14%-29.30%-51.49%-82.60%183.59%

Correlation

The correlation between PMVP and PRLD is 0.23, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.23

Correlation (3Y)
Balances recent behavior with more history.

0.20

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.24

Correlation (All Time)
Calculated using the full available price history since Sep 25, 2020

0.23

Fundamentals

Market Cap

PMVP:

$59.73M

PRLD:

$249.93M

EPS

PMVP:

-$1.47

PRLD:

-$1.05

PB Ratio

PMVP:

0.68

PRLD:

6.02

Total Revenue (TTM)

PMVP:

$0.00

PRLD:

$16.72M

Gross Profit (TTM)

PMVP:

-$97.00K

PRLD:

$11.30M

EBITDA (TTM)

PMVP:

-$80.43M

PRLD:

-$82.17M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PMVP vs. PRLD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

PMVP
PMVP Risk / Return Rank: 2929
Overall Rank
PMVP Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
PMVP Sortino Ratio Rank: 3333
Sortino Ratio Rank
PMVP Omega Ratio Rank: 3333
Omega Ratio Rank
PMVP Calmar Ratio Rank: 2525
Calmar Ratio Rank
PMVP Martin Ratio Rank: 2626
Martin Ratio Rank

PRLD
PRLD Risk / Return Rank: 9595
Overall Rank
PRLD Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
PRLD Sortino Ratio Rank: 9595
Sortino Ratio Rank
PRLD Omega Ratio Rank: 9696
Omega Ratio Rank
PRLD Calmar Ratio Rank: 9797
Calmar Ratio Rank
PRLD Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

PMVP vs. PRLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PMV Pharmaceuticals, Inc. (PMVP) and Prelude Therapeutics Incorporated (PRLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PMVPPRLDDifference
Sharpe ratioReturn per unit of total volatility

-2.45

Sortino ratioReturn per unit of downside risk

-3.54

Omega ratioGain probability vs. loss probability

1.01

1.51

-0.50

Calmar ratioReturn relative to maximum drawdown

-0.48

6.18

-6.67

Martin ratioReturn relative to average drawdown

-0.84

13.70

-14.54

PMVP vs. PRLD - Sharpe Ratio Comparison

The current PMVP Sharpe Ratio is -0.28, which is lower than the PRLD Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of PMVP and PRLD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PMVP vs. PRLD - Drawdown Comparison

The maximum PMVP drawdown since its inception was -98.64%, roughly equal to the maximum PRLD drawdown of -99.33%. Use the drawdown chart below to compare losses from any high point for PMVP and PRLD.


Loading charts...

Drawdown Indicators


PMVPPRLDDifference

Max Drawdown

Largest peak-to-trough decline

-98.64%

-99.33%

+0.69%

Max Drawdown (1Y)

Largest decline over 1 year

-41.67%

-70.10%

+28.43%

Max Drawdown (3Y)

Largest decline over 3 years

-90.61%

-90.42%

-0.19%

Max Drawdown (5Y)

Largest decline over 5 years

-97.71%

-98.42%

+0.71%

Current Drawdown

Current decline from peak

-98.18%

-95.21%

-2.97%

Average Drawdown

Average peak-to-trough decline

-80.21%

-85.39%

+5.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.89%

31.57%

-7.68%

Volatility

PMVP vs. PRLD - Volatility Comparison

The current volatility for PMV Pharmaceuticals, Inc. (PMVP) is 20.09%, while Prelude Therapeutics Incorporated (PRLD) has a volatility of 25.84%. This indicates that PMVP experiences smaller price fluctuations and is considered to be less risky than PRLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PMVPPRLDDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.09%

25.84%

-5.75%

Volatility (6M)

Calculated over the trailing 6-month period

51.64%

78.30%

-26.66%

Volatility (1Y)

Calculated over the trailing 1-year period

71.30%

200.19%

-128.89%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.94%

125.66%

-48.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

76.86%

121.39%

-44.53%

Dividends

PMVP vs. PRLD - Dividend Comparison

Neither PMVP nor PRLD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PMVP vs. PRLD - Financials Comparison

This section allows you to compare key financial metrics between PMV Pharmaceuticals, Inc. and Prelude Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


PMVP and PRLD have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PRLD has higher volatility (25.84%) compared to PMVP (20.09%). In terms of maximum drawdown, PMVP dropped -98.64% vs PRLD's -99.33%.

PRLD currently has the higher Sharpe Ratio (2.17 vs -0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PMVP and PRLD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer